<i>In vivo</i>, peritumoral administration of PPP/MTX-Mn markedly suppressed tumor growth in a melanoma-bearing mouse model, reduced the tumor burden, and significantly decreased Ki-67 expression. This evidence concerns the gene MKI67 and neoplasm.